Yingjie Zhang,1 Xiaoguang Li,1 Jinning Hou,1 Yongxue Huang,2 Wenfang Xu1 1Department of Medicinal Chemistry, School of Pharmacy, Shandong University, Ji’nan, 2Weifang Bochuang International Biological Medicinal Institute, Weifang, Shandong, People&
Li X, Hou J, Huang Y, Zhang Y, Xu W
core
Microglial histone deacetylase-3 conditional deletion attenuates neurological deficits after intracerebral hemorrhage. [PDF]
Watson NJ, Xu H, Sukumari-Ramesh S.
europepmc +1 more source
Inhibition of histone deacetylase 3 in dental mesenchyme regulates the development of tooth root. [PDF]
Niibe K +9 more
europepmc +1 more source
Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury. [PDF]
Zhao Y +9 more
europepmc +1 more source
Histone deacetylase 3 promotes hypoxia-induced human pulmonary arterial smooth muscle cell proliferation by modulating the CSF2-JAK2-STAT5 signaling pathway. [PDF]
Zhang J, Fan Y, Gao Y, Jin Y.
europepmc +1 more source
miR-4286 functions in osteogenesis and angiogenesis via targeting histone deacetylase 3 and alleviates alcohol-induced bone loss in mice. [PDF]
Yu H +11 more
europepmc +1 more source
Correlations of serum histone deacetylase 3 and thrombospondin-1 levels with cardiac function grades, ventricular remodeling, and prognosis in patients with chronic heart failure. [PDF]
Cheng J, Cheng T.
europepmc +1 more source
Age-Dependent Histone Deacetylase 3 Regulation by βA3/A1-Crystallin and Inositol Hexaphosphate in Retinal Pigmented Epithelial Cells Reveals a Novel Pathway in Age-Related Macular Degeneration. [PDF]
Chatterjee S +16 more
europepmc +1 more source
Corrigendum: Histone Deacetylase 3 Aggravates Type 1 Diabetes Mellitus by Inhibiting Lymphocyte Apoptosis Through the microRNA-296-5p/Bcl-xl Axis. [PDF]
Hu Q, Che G, Yang Y, Xie H, Tian J.
europepmc +1 more source
The Use of Histone Deacetylase Inhibitors: Novel Advances in Cancer Treatment
This thesis explores the role of histone deacetylase inhibitors (HDACis) as promising epigenetic therapies in cancer treatment. HDACis modulate gene expression by inhibiting histone deacetylases, leading to the reactivation of tumor suppressor genes ...
Raad , Lara
core

